Skip to main content
. 2011 Apr 18;11:143. doi: 10.1186/1471-2407-11-143

Figure 5.

Figure 5

Comparison of survival outcome between patients with molecular subtype IV breast cancer treated with CMF and CAF. Detailed comparisons of pertinent clinical parameters between these two treatment groups are summarized in Table 4. The numbers in parentheses represent the number of events. P values were determined by log-rank test. The upper panel is metastasis-free survival curves and the lower panel is overall survival curves.